In a report released today, Matthew Weston from UBS maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with a price target of CHF270.00. The company’s shares closed yesterday at ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

DelveInsight's Respiratory Disease Testing Market Insights report provides the current and forecast market analysis, individual ...

In May 2024, GSK announced positive headline results from the phase III clinical trials SWIFT-1 and SWIFT-2, which assessed the efficacy and safety of depemokimab versus placebo in adults and ...

Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...

The lawsuit – filed on Tuesday, Oct. 29, 2024, -- accuses Prospect Medical of breaking the 2016 Asset Purchases Agreement by ...

FRANKFURT (Reuters) -Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes was linked to an ...

Oculis Holding AG (OCS) shares soared 7.9% in the last trading session to close at $17.05. The move was backed by solid volume with far more shares changing hands than in a normal session.

EXCLUSIVE: Missouri Attorney General Andrew Bailey on Thursday announced an investigation into Google for allegedly suppressing conservative speech during the election cycle. FOX Business has ...

Roche's Q3 sales rose 9% year over year, reaching 15.14 billion Swiss francs (~$17.5 billion). Ocrevus sales increased 11% to 1.69 billion Swiss francs, while Vabysmo surged 59%. On Wednesday ...

A Novo Nordisk spokesperson, commenting on the Roche CEO's remarks, said: "If the acquisition is approved, Novo Nordisk will purchase three manufacturing sites from Novo Holdings. Catalent will ...